Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Plucked hair follicles can help diagnose scalp lupus.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

TNF-alpha inhibitors can cause various immune-related skin issues.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Acne is caused by multiple factors including oil production, bacteria, inflammation, and possibly diet and environment.